Asked by: David Mundell (Conservative - Dumfriesshire, Clydesdale and Tweeddale)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with Cabinet colleagues on departmental responsibility for cannabis-based medicinal products.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Home Office leads on drug legislation and the Department of Health and Social Care and its Arm’s Length Bodies oversee healthcare and medicine regulation. This regulatory framework applies to all drugs under Schedules 1-5 of the Misuse of Drugs Regulations 2001, including cannabis-based products for medicinal use.
No changes are planned to the current responsibilities. The Government has asked the Advisory Council on the Misuse of Drugs (ACMD) to review the impact of the 2018 change in the law, which enabled the widened use of cannabis-based products for medicines, and will consider the recommendations in the usual way.
Asked by: David Mundell (Conservative - Dumfriesshire, Clydesdale and Tweeddale)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce syphilis diagnoses among heterosexual populations; and what targeted interventions he is (a) planning and (b) implementing.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) published a sexually transmitted infection (STI) prioritisation framework in 2024 to inform local prioritisation decisions for the control of STIs, including syphilis. The UKHSA’s STI Prioritisation Framework is available at the following link:
https://www.gov.uk/government/publications/sti-prioritisation-framework
The UKHSA also previously published a Syphilis Action Plan, which is focused on actions to control and prevent syphilis, which include:
The wider population of heterosexual men and women should be offered a full sexual health screen when clinically appropriate, and especially when attending sexual health services. The UKHSA’s Syphilis Action Plan in available at the following link:
https://www.gov.uk/government/publications/syphilis-public-health-england-action-plan
Asked by: David Mundell (Conservative - Dumfriesshire, Clydesdale and Tweeddale)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the transmission of syphilis (a) among high-risk groups and (b) in general.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health Security Agency (UKHSA) published a sexually transmitted infection (STI) prioritisation framework in 2024 to inform local prioritisation decisions for the control of STIs, including syphilis. The UKHSA’s STI Prioritisation Framework is available at the following link:
https://www.gov.uk/government/publications/sti-prioritisation-framework
The UKHSA also previously published a Syphilis Action Plan, which is focused on actions to control and prevent syphilis, which include:
The wider population of heterosexual men and women should be offered a full sexual health screen when clinically appropriate, and especially when attending sexual health services. The UKHSA’s Syphilis Action Plan in available at the following link:
https://www.gov.uk/government/publications/syphilis-public-health-england-action-plan